Sign in

Private company

Avid Bioservices, Inc.

Avid Bioservices, Inc. is an American pharmaceutical preparations company based in Tustin, active since 1996.2

Last updated Oct 21, 2026.

Overview

$139.9MRevenue, fiscal 20243
-$140.8MNet income, fiscal 20243
  • IndustryPharmaceutical Preparations2
  • HeadquartersTustin, United States2
  • Incorporated inDE4
  • Business address14191 Myford Road, Tustin, Ca 927804
  • Filer categoryAccelerated filer4
  • Legal formCorporation2
  • LEI549300GRUS3ZMGP8MX222
  • StatusActive2
  • LEI statusIssued and current2
  • Registered addressC/O CORPORATION SERVICE COMPANY, 19808 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 26670302

See how the biggest companies compare on our leaderboards

Practices (“CGMP”) clinical and commercial manufacturing of biologics for the biotechnology and biopharmaceutical industries.5 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2024

5.2%Gross margin3
-13.3%Operating margin3
-100.6%Net margin3
-6.3%Revenue growth, 20243
-231.2%Return on equity3
0.89×Debt to equity3
-$20.9MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Cost of revenue48¢$132.6M
  • Selling, general and admin9¢$26.0M
  • Interest2¢$4.3M
  • Income tax41¢$113.8M

Out of $139.9M in revenue.3 The company lost money this year.

Where each dollar of operating cash went, fiscal 2024

  • Capital spending100¢$31.8M

Out of $11.0M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.3

Financial statements

Revenue6789103$139.9M in 2024+143% since 2017
0$50.0M$100.0M$150.0M2017: $57.6M$57.6M20172018: $53.6M$53.6M2018−7%2019: $53.6M$53.6M2019−0%2020: $59.7M$59.7M2020+11%2021: $95.9M$95.9M2021+61%2022: $119.6M$119.6M2022+25%2023: $149.3M$149.3M2023+25%2024: $139.9M$139.9M2024−6%
Gross profit6789103$7.3M in 2024−62% since 2017
-$10.0M0$10.0M$20.0M$30.0M$40.0M2017: $19.4M$19.4M20172018: -$2.9M-$2.9M20182019: $7.2M$7.2M20192020: $3.9M$3.9M2020−46%2021: $29.3M$29.3M2021+645%2022: $36.6M$36.6M2022+25%2023: $31.5M$31.5M2023−14%2024: $7.3M$7.3M2024−77%
Operating income6789103-$18.7M in 2024
-$30.0M-$20.0M-$10.0M0$10.0M$20.0M2017: $1.3M$1.3M20172018: -$20.6M-$20.6M20182019: -$5.6M-$5.6M2019−73%2020: -$10.9M-$10.9M2020+95%2021: $12.2M$12.2M20212022: $15.4M$15.4M2022+26%2023: $3.6M$3.6M2023−77%2024: -$18.7M-$18.7M2024
Net income6789103-$140.8M in 2024+400% since 2017
-$200.0M-$100.0M0$100.0M$200.0M2017: -$28.2M-$28.2M20172018: -$21.8M-$21.8M2018−23%2019: -$4.2M-$4.2M2019−81%2020: -$10.5M-$10.5M2020+148%2021: $11.2M$11.2M20212022: $127.7M$127.7M2022+1039%2023: $259.0K$259.0K2023−100%2024: -$140.8M-$140.8M2024
Fiscal year20172018201920202021202220232024
Revenue$57.6M6$53.6M7$53.6M8$59.7M9$95.9M10$119.6M3$149.3M3$139.9M3
Cost of revenue$38.3M6$56.5M6$46.4M6$55.8M9$66.6M10$82.9M3$117.8M3$132.6M3
Gross profit$19.4M6-$2.9M7$7.2M8$3.9M9$29.3M10$36.6M3$31.5M3$7.3M3
Research and development$28.3M13
Selling, general and admin$18.1M6$16.5M7$12.8M8$14.5M9$17.1M10$21.2M3$27.9M3$26.0M3
Operating expenses$21.2M3$27.9M3$26.0M3
Operating income$1.3M6-$20.6M7-$5.6M8-$10.9M9$12.2M10$15.4M3$3.6M3-$18.7M3
Interest$11.0K8$8.0K9$1.2M10$2.7M3$3.0M3$4.3M3
Income before tax$12.7M3$1.6M3-$26.9M3
Income tax$06$07-$284.0K8$09$010-$115.0M3$1.3M3$113.8M3
Net income-$28.2M6-$21.8M7-$4.2M8-$10.5M9$11.2M10$127.7M3$259.0K3-$140.8M3
Earnings per share-$0.168-$0.279$0.0610$2.083$0.003-$2.233
Earnings per share (diluted)-$0.168-$0.279$0.0610$1.843$0.003-$2.233
Shares (weighted, basic)61.5M shares362.3M shares363.2M shares3
Shares (weighted, diluted)70.5M shares363.8M shares363.2M shares3

Compare Avid Bioservices, Inc. with another company

Corporate structure

Avid Bioservices, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Avid Bioservices, Inc.

  • Avid Bioservices, Inc. Tustin, California, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Avid Bioservices, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$223.1M3 Apr 30, 2024$208.1M3 Apr 30, 2023+7.2%
Accumulated depreciation$36.6M3 Apr 30, 2024$30.4M3 Apr 30, 2023+20.6%
Property and equipment, net$186.5M3 Apr 30, 2024$177.8M3 Apr 30, 2023+4.9%
Finance-lease assets$9.3M3 Apr 30, 2024$2.5M3 Apr 30, 2023+266.5%
Operating-lease assets (leased space)$41.2M3 Apr 30, 2024$42.8M3 Apr 30, 2023−3.8%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$38.1M3 Apr 30, 2024$38.5M3 Apr 30, 2023−1.1%
Marketable securities, current$4.4M3 Apr 30, 2024$03 Apr 30, 2023

Inventory

ItemLatestA year beforeChange
Inventory, total$30.4M3 Apr 30, 2024$43.9M3 Apr 30, 2023−30.8%

Leadership

Who has led Avid Bioservices, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Roger J. Lias2018–2019
  2. Richard B. Hancock2019–2020
  3. Nicholas Stewart Green2020–2025

President

  1. Roger J. Lias2017–2019
  2. Richard B. Hancock2019–2020
  3. Nicholas Stewart Green2020–2025

Chief financial officer

  1. Paul J. Lytle2006–2017
  2. Daniel Ryan Hart2018–2025
2010201520202025
Board members and other officers (22)

Former names

  • PEREGRINE PHARMACEUTICALS INCDec 11, 2000 to Dec 26, 20174
  • TECHNICLONE CORP/DE/Oct 3, 1997 to Jul 31, 20004
  • TECHNICLONE INTERNATIONAL CORPDec 14, 1995 to Feb 11, 19974

Timeline

  1. Feb 5, 20258-K Entered a material agreement; Completed an acquisition or sale; Listing notice or transfer41
  2. Feb 5, 20258-K Entered a material agreement; Completed an acquisition or sale; Listing notice or transfer42
  3. Jan 30, 20258-K Shareholder vote; Regulation FD disclosure43
  4. Dec 10, 20248-K Results of operations44
  5. Nov 7, 20248-K Entered a material agreement; Regulation FD disclosure45
  6. Oct 17, 20248-K Executive or director change; Shareholder vote46
  7. Sep 9, 20248-K Results of operations; Regulation FD disclosure47
  8. Aug 29, 20248-K Executive or director change48
  9. Jul 2, 20248-K Results of operations; Regulation FD disclosure49
  10. Apr 25, 20248-K Results of operations; Regulation FD disclosure50
  11. Mar 20, 20248-K Listing notice or transfer51
  12. Mar 14, 20248-K Entered a material agreement; New debt or obligation52
  13. Jul 31, 2020New chief executive Nicholas Stewart Green becomes CEO15
  14. May 8, 2019New chief executive Richard B. Hancock becomes CEO16
  15. May 3, 2018New chief executive Roger J. Lias becomes CEO17
  16. Sep 25, 1996Founded Avid Bioservices, Inc. is founded2

Calendar

When it reported results

  1. Dec 10, 2024Reported quarterly or annual results44
  2. Sep 9, 2024Reported quarterly or annual results47
  3. Jul 2, 2024Reported quarterly or annual results49
  4. Apr 25, 2024Reported quarterly or annual results50
  5. Mar 7, 2024Reported quarterly or annual results53
  6. Dec 7, 2023Reported quarterly or annual results54
  7. Sep 7, 2023Reported quarterly or annual results55
  8. Jun 21, 2023Reported quarterly or annual results56

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

343 filings to the SEC since October 2021: 4 annual reports, 12 quarterly reports, 42 major events, 188 insider forms, 32 large holders, 65 other. The latest 20:

  1. May 15, 2025SCHEDULE 13G/A EDGAR
  2. Feb 18, 202515-12G EDGAR
  3. Feb 14, 2025SCHEDULE 13G/A EDGAR
  4. Feb 7, 20254 EDGAR
  5. Feb 7, 20254 EDGAR
  6. Feb 7, 20254 EDGAR
  7. Feb 7, 20254 EDGAR
  8. Feb 7, 20254 EDGAR
  9. Feb 7, 20254 EDGAR
  10. Feb 7, 20254 EDGAR
  11. Feb 7, 20254 EDGAR
  12. Feb 7, 20254 EDGAR
  13. Feb 7, 20254 EDGAR
  14. Feb 7, 20254 EDGAR
  15. Feb 5, 202525-NSE EDGAR
  16. Feb 5, 2025S-8 POS EDGAR
  17. Feb 5, 2025S-8 POS EDGAR
  18. Feb 5, 2025S-8 POS EDGAR
  19. Feb 5, 2025S-8 POS EDGAR
  20. Feb 5, 2025S-8 POS EDGAR

The 343 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

109 open-market trades by officers, directors and large owners since October 2021: 3 buys and 106 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jan 10, 2025Richieri Richard A.Chief Operations OfficerSale2,483$12.37$30.7KForm 4
Dec 26, 2024Richieri Richard A.Chief Operations OfficerSale3,843$12.22$47.0KForm 4
Dec 26, 2024Kwietniak Matthew R.Chief Commercial OfficerSale13,390$12.22$163.6KForm 4
Dec 26, 2024Hart Daniel RChief Financial OfficerSale22,813$12.22$278.8KForm 4
Dec 26, 2024Green Nicholas StewartPresident & CEOSale145,911$12.22$1.8MForm 4
Dec 24, 2024Green Nicholas StewartPresident & CEOSale51,653$12.27$633.8KForm 4
Dec 23, 2024Green Nicholas StewartPresident & CEOSale100,000$12.28$1.2MForm 4
Dec 20, 2024Green Nicholas StewartPresident & CEOSale75,000$12.31$923.2KForm 4
Oct 14, 2024Kwietniak Matthew R.Chief Commercial OfficerSale119$10.15$1.2KForm 4
Oct 10, 2024Richieri Richard A.Chief Operations OfficerSale2,232$10.05$22.4KForm 4
Oct 10, 2024Kwietniak Matthew R.Chief Commercial OfficerSale982$10.05$9.9KForm 4
Oct 10, 2024Green Nicholas StewartPresident & CEOSale17,173$10.05$172.6KForm 4
Jul 15, 2024Richieri Richard A.Chief Operations OfficerSale530$8.36$4.4KForm 4
Jul 15, 2024Kwietniak Matthew R.Chief Commercial OfficerSale307$8.36$2.6KForm 4
Jul 12, 2024Kwietniak Matthew R.Chief Commercial OfficerSale119$8.05$958Form 4
Jul 11, 2024Richieri Richard A.Chief Operations OfficerSale1,515$7.54$11.4KForm 4
Jul 10, 2024Richieri Richard A.Chief Operations OfficerSale1,025$7.54$7.7KForm 4
Jul 10, 2024Kwietniak Matthew R.Chief Commercial OfficerSale444$7.54$3.3KForm 4
Jul 10, 2024Green Nicholas StewartPresident & CEOSale7,657$7.54$57.7KForm 4
Apr 30, 2024Ziebell Mark RV. P., General CounselSale1,643$7.40$12.2KForm 4

All 109 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Avid Bioservices, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARAvid Bioservices, Inc.1
  • CIK0000704562
  • Employer ID (EIN)95-36984221
  • Filer statusAccelerated filer1
  • Incorporated inDelaware1
  • Fiscal year endsApril 301
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address14191 Myford Road, Tustin, CA 927801
  • Phone714.508.61001
  • Shares outstanding63,963,302 as of Dec 3, 202412
  • Public float$385.8M as of Oct 31, 20233
  • On EDGAR sinceSep 14, 19951
  • Filings1,388 in all: 4 (459), 8-K (325), 10-Q (89), 424B2 (54), SC 13G/A (45), DEFA14A (38), 144 (31), DEF 14A (30)1
    All 51 form types

    10-K (29), 3 (24), S-3/A (23), SC 13G (23), SC 13D/A (22), S-3 (21), PRE 14A (19), 424B5 (17), S-8 (15), CORRESP (12), NO ACT (12), CT ORDER (11), UPLOAD (11), 10-K/A (10), S-8 POS (10), DFAN14A (7), EFFECT (7), 10-Q/A (5), 8-K/A (5), 424B4 (4), SC 13D (3), SCHEDULE 13G/A (3), 25-NSE (2), 8-A12B (2), 8-A12B/A (2), 15-12G (1), 25 (1), 4/A (1), 5 (1), 8-B12G (1), ARS (1), CERTNAS (1), DEFM14A (1), DEFR14A (1), FWP (1), NT 10-K (1), NT 10-Q (1), PREC14A (1), PREM14A (1), PRES14A (1), REGDEX (1), S-3ASR (1), SCHEDULE 13G (1)

  • Latest filingsAnnual report (10-K) Jul 2, 2024
    Quarterly report (10-Q) Dec 10, 2024
    Proxy statement (DEF 14A) Aug 28, 2024
    Latest 8-K (8-K) Feb 5, 2025

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66